Herceptin halved breast cancer recurrence in trials
Genentech’s Herceptin breast cancer treatment nearly cuts in half the risk that a certain type of breast cancer will recur ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.